Drug Shortage Report for TEVA-SIMVASTATIN

Last updated on 2017-08-26 History
Report ID 18004
Drug Identification Number 02250160
Brand name TEVA-SIMVASTATIN
Common or Proper name SIMVASTATIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SIMVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size PP 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-01
Estimated end date
Actual end date 2017-08-25
Shortage status Resolved
Updated date 2017-08-26
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2017-08-26 English Compare
v2 2017-08-02 French Compare
v1 2017-08-02 English Compare